The present invention relates to methods of regulating an immune response in an individual and, more particularly, to methods and agents which target NIK and NIK binding proteins participating in both the canonical and alternative NF-.kappa.B activation pathway, to methods of identifying molecules/agents for modulation of NIK activity and to the molecules/agents obtainable by the method thereof.